Atrial Fibrillation Program
Comprehensive digital health program for AFib management
Software · Cloud SaaSCompany source
Company profile
About Story Health
Story Health is a healthcare technology company that reimagines complex care management and virtual care delivery for patients with chronic conditions. Founded by veterans from Google, Verily Life Sciences, Athenahealth, and clinical cardiology, the company brings together virtual care and artificial intelligence to revolutionize treatment for people with heart failure and other complex medical conditions by extending the reach of specialists into the home. The company's platform supports multiple clinical programs including heart failure, hypertension, atrial fibrillation, diabetes, COPD, and transitions of care. Story Health's approach centers on four key pillars: home-centric care that extends outside clinic walls, medication management with focus on effective medication utilization, flexible support models that range from care team extension to full management, and scalable integration with deep technical and clinical capabilities. Story Health partners with leading health systems and payers to transform care delivery models. The company offers specific programs including HF Home Titration, HF Volume Management, HF Advanced Therapy Evaluation, and Refractory Hypertension management. Their AI-enabled clinician tools create better care experiences and health outcomes by meeting patients where they need care most. In 2024, Story Health was acquired by Innovaccer to pioneer AI agents that augment specialty care teams.
Company description Story Health official website
Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Story Health?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Atrial Fibrillation
- COPD
- Diabetes
- Heart Failure
- Hypertension (Refractory)
- Transition of Care
Who it serves
- Cardiology Departments
- Health Systems
- Payers
- Primary Care Providers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
Acquired by Innovaccer to pioneer AI agents that augment specialty care teams (announced as latest news on website)
Partnerships
Recorded partners
- Innovaccer (acquirer)
- Intermountain Healthcare Heart and Vascular Program
- Pearl Health
- WVU Heart and Vascular Institute
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
HF Advanced Therapy Evaluation
Assessment program for advanced heart failure therapy candidacy
Software · Cloud SaaSCompany source
HF Home Titration
Heart failure medication optimization program delivered in the home
Software · Cloud SaaSCompany source
HF Volume Management
Heart failure volume monitoring and management program
Software · Cloud SaaSCompany source
Refractory Hypertension Program
Digital program for managing difficult-to-control hypertension
Software · Cloud SaaSCompany source
Story Health Platform
AI-powered, tech-enabled platform for continuous specialty care delivery
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Remote digital intervention targeting heart failure medical therapy: a randomized controlled trial.Lancet regional health. Americas · Jun 1, 2026
Rationale, design, and baseline characteristics of the virtual care to improve heart failure outcomes (VITAL-HF) trial.American heart journal · Dec 1, 2025
Patient Perspectives on Digital Interventions to Manage Heart Failure Medications: The VITAL-HF Pilot.Journal of clinical medicine · Jul 14, 2023
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Reduced heart failure mortality
Through evidence-based care and patient engagement
Reduced heart failure readmissions
Via home-centric care and medication management
Improved quality of life
For heart failure patients through empowerment and engagement
Increased medication adherence
Life-saving medications for heart failure patients
Kettering Health Partnership
Digital support program for heart failure patients
Launched patient care support program powered by Story Health
Intermountain Health
Heart failure program using digital health solution to improve clinical and financial outcomes
Promising clinical and financial results; expanded partnership to hypertension patients across five sites
Zing Health
Unique cardiology benefit for Medicare Advantage members with high-risk cardiology conditions
Members can access care anywhere with Story Health
Guidehealth
Value-based cardiology care program for clinically integrated networks
Improved health outcomes and total costs for patients with heart-related and chronic conditions
Saint Luke's Mid America Heart Institute
Comprehensive digital health program for atrial fibrillation patients
Magnifies specialty providers' ability to see more patients and improve their quality of life
Pearl Health
Partnership to provide PCPs access to specialty care partners in value-based care transition
Better outcomes for patients and providers in value-based care models
WVU Heart and Vascular Institute
Partnership to reduce heart failure mortality and improve quality of life
New approach in engaging and empowering patients to reduce heart failure mortality
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Story Health
Recent articles published on Story Health's official website.
Featured stories
Read on Story HealthTech-Enabled Chronic Care: Where Intelligence Meets DeliveryFeb 26, 2026•Article
Read on Story HealthThe Remote Chronic Care Operating Model RHT Expects You to HaveFeb 26, 2026•Article
Read on Story HealthChoosing the Right ACCESS Track: A Practical Decision Framework for Health Systems and Provider GroupsFeb 6, 2026•Article
Read on Story HealthHow AI Is Redefining the Rules of Cardiology Specialty CareDec 19, 2025•ArticleHow AI Is Redefining the Rules of Cardiology Specialty Care
Read on Story Health07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Chronic Disease Management & Digital Therapeutics
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.